MedWatch

Fresh millions for Danish biotech company

A Danish biotech company has raised millions through a capital increase. The money will go towards bringing one of the company’s cancer drugs to phase II. The company is also in talks with potential partners concerning another cancer drug.

Foto: Colourbox

The biotech company Cytovac has raised 10.5 million kroner (USD 1.9 million) through a capital increase from private investors.

The company focuses on research and development of drugs to strengthen the immune systems of cancer patients, based on the patients’ own cells.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier